|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2007-7-19
|
|
pubmed:abstractText |
Current American Diabetes Association (ADA)/European Association for the Study of Diabetes (EASD) treatment guidelines recommend metformin (which does not promote weight gain) as the first-line antihyperglycaemic drug for patients with type 2 diabetes. However, when metformin fails, the recommended add-on treatment options (sulphonylureas, glitazones and basal insulin) can lead to significant weight gain. This article reviews the effect on body weight of current treatments for type 2 diabetes and discusses the potential impact of weight gain in this patient group.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1473-4877
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
23
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1493-507
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:17559747-Adenosine Deaminase Inhibitors,
pubmed-meshheading:17559747-Body Weight,
pubmed-meshheading:17559747-Diabetes Mellitus, Type 2,
pubmed-meshheading:17559747-Dipeptidyl Peptidase 4,
pubmed-meshheading:17559747-Dipeptidyl-Peptidase IV Inhibitors,
pubmed-meshheading:17559747-Gastrointestinal Hormones,
pubmed-meshheading:17559747-Glycoproteins,
pubmed-meshheading:17559747-Humans,
pubmed-meshheading:17559747-Hypoglycemic Agents,
pubmed-meshheading:17559747-Obesity,
pubmed-meshheading:17559747-Weight Gain
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
A review of the effects of antihyperglycaemic agents on body weight: the potential of incretin targeted therapies.
|
|
pubmed:affiliation |
Department of Medicine, University of Birmingham and Heart of England National Health Service Foundation Trust (Teaching), Birmingham, UK. anthony.barnett@heartofengland.nhs.uk
|
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|
